|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0800 THB | -11.11% |
|
0.00% | -52.94% |
| 07-20 | X Bioscience Reports Higher Impairment Charges in Q1 | MT |
| 07-16 | X Bioscience Public Company Limited Announces CEO Changes | CI |
Company Valuation: Wow Factor
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,296 | 3,532 | 1,612 | 731.7 | 1,030 | 178.6 |
| Change | - | 7.16% | -54.38% | -54.59% | 40.78% | -82.67% |
| Enterprise Value (EV) 1 | 3,454 | 3,973 | 2,068 | 1,120 | 1,375 | 414.2 |
| Change | - | 15.02% | -47.94% | -45.85% | 22.81% | -69.88% |
| P/E | -11.7x | -12.8x | -2.8x | -4.22x | -2.62x | -0.15x |
| PBR | 3.48x | 5.25x | 15.7x | 4x | 2.01x | 0.82x |
| PEG | - | 8.27x | -0x | 0.1x | -0.1x | 0x |
| Capitalization / Revenue | 7.93x | 8.56x | 4.68x | 2.35x | 3.23x | 1.38x |
| EV / Revenue | 8.31x | 9.63x | 6x | 3.59x | 4.31x | 3.2x |
| EV / EBITDA | -52.7x | -20.7x | -255x | -10.9x | -6.13x | -0.95x |
| EV / EBIT | -26.2x | -14.3x | -20.3x | -9.3x | -5.48x | -0.91x |
| EV / FCF | 14.7x | -34.8x | -23.1x | -11.3x | -9.29x | -0.78x |
| FCF Yield | 6.78% | -2.87% | -4.34% | -8.88% | -10.8% | -129% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.415 | -2.378 | -4.954 | -1.177 | -1.414 | -1.167 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 415.6 | 412.5 | 344.5 | 311.8 | 319.2 | 129.7 |
| EBITDA 1 | -65.57 | -191.7 | -8.124 | -102.7 | -224.5 | -436.4 |
| EBIT 1 | -131.6 | -278.8 | -101.9 | -120.4 | -251.2 | -454.3 |
| Net income 1 | -238.8 | -276.5 | -576 | -147.5 | -260.2 | -468.9 |
| Net Debt 1 | 158.1 | 441 | 456.8 | 388.3 | 345.4 | 235.7 |
| Reference price 2 | 28.3500 | 30.3800 | 13.8600 | 4.9700 | 3.7100 | 0.1700 |
| Nbr of stocks (in thousands) | 116,273 | 116,273 | 116,273 | 147,228 | 277,657 | 1,050,322 |
| Announcement Date | 3/1/21 | 2/25/22 | 2/28/23 | 2/16/24 | 2/28/25 | 2/25/26 |
1THB in Million2THB
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 32.75M | |
| 21.58x | 9.73x | 14.48x | 1.35% | 88.52B | |
| 26.53x | 15.47x | 19.56x | 3.38% | 65.63B | |
| 31.83x | 5.24x | 10.47x | 1.94% | 56.33B | |
| 21.1x | 7.99x | 13.31x | 1.76% | 54.78B | |
| 26.71x | 10.38x | 17.3x | 1.26% | 53.19B | |
| 35.64x | 16.32x | 25.63x | 1.88% | 20.1B | |
| 20.79x | 8.08x | 12.95x | 2.4% | 17.45B | |
| 13.16x | 6.87x | 9.79x | 7.44% | 15.44B | |
| 22.92x | 8.38x | 14.6x | 1.86% | 10.17B | |
| Average | 24.47x | 9.83x | 15.34x | 2.59% | 38.16B | |
| Weighted average by Cap. | 24.99x | 10.02x | 15.32x | 2.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- XBIO Stock
- Valuation Wow Factor
Select your edition
All financial news and data tailored to specific country editions
